Journal of Neuroscience,
Journal Year:
2023,
Volume and Issue:
43(47), P. 7899 - 7901
Published: Nov. 22, 2023
Alzheimer's
disease
(AD)
is
a
neurodegenerative
disorder
characterized
by
the
aggregation
of
β-amyloid
and
tau.
While
cognitive
impairment
primary
clinical
manifestation
AD,
patients
also
experience
noncognitive
symptoms,
such
as
disordered
sleep.
These
include
sleep
loss
Medicine,
Journal Year:
2025,
Volume and Issue:
104(5), P. e41346 - e41346
Published: Jan. 31, 2025
One
third
of
a
person's
life
is
in
state
sleep,
and
good
sleep
quality
one
the
indicators
health.
Long-term
insomnia
has
great
impact
on
patients'
life,
physical
mental
state.
Especially
elderly,
long-term
will
induce
variety
chronic
diseases,
seriously
affecting
life.
Because
characteristics
physiological
structure
elderly
its
unique
different
from
that
young.
This
article
reviews
terms
symptom,
pathogenesis
treatment.
By
elaborating
senile
insomnia,
we
hope
to
provide
ideas
for
clinical
treatment
insomnia.
Frontiers in Aging Neuroscience,
Journal Year:
2025,
Volume and Issue:
17
Published: Feb. 4, 2025
Sleep
disturbances
are
common
in
Alzheimer’s
disease
(AD)
and
AD-related
dementia
(ADRD).
We
performed
a
sleep
study
on
Tg-SwDI
mice,
cerebral
amyloid
angiopathy
(CAA)
model,
age-matched
wild-type
(WT)
control
mice.
The
results
showed
that
at
12
months
of
age,
the
hemizygous
mice
spent
significantly
more
time
non-rapid
eye
movement
(NREM)
(44.6
±
2.4%
versus
35.9
2.5%
WT)
had
much
shorter
average
length
wake
bout
during
dark
(active)
phase
(148.5
8.7
s
203.6
13.0
WT).
Histological
analysis
revealed
stark
decreases
orexin
immunoreactive
(orexin-IR)
neuron
number
soma
size
these
(cell
number:
2187
97.1
3318
137.9
WT.
size:
109.1
8.1
μm
2
160.4
6.6
WT),
while
melanin-concentrating
hormone
(MCH)
(MCH-IR)
neurons
remained
unchanged
4256
273.3
4494
326.8
220.1
13.6
202.0
7.8
apoptotic
cell
death
marker
cleaved
caspase-3
(Caspase-3-IR)
percentage
orexin-IR
was
higher
than
WT
controls.
This
selective
loss
could
be
associated
with
abnormal
phenotype
Further
studies
needed
to
determine
cause
cells
relevant
effects
cognition
impairments
this
mouse
model
microvascular
amyloidosis.
Deleted Journal,
Journal Year:
2025,
Volume and Issue:
2(1)
Published: March 8, 2025
We
examine
the
relationship
between
sleep,
glymphatics
and
Alzheimer's
disease
(AD),
recent
work
questioning
glymphatic
clearance
during
sleep.
highlight
a
need
for
understanding
and/or
other
mechanism
of
review
flow
measurement
methods.
Further,
we
explore
dual
orexin
receptor
antagonists
(DORAs)
potential
to
mitigate
AD
sleep
disturbances
enhance
clearance.
Further
research
could
elucidate
linkage
DORAs,
improved
reducing
pathophysiology.
eNeuro,
Journal Year:
2024,
Volume and Issue:
11(6), P. ENEURO.0004 - 24.2024
Published: June 1, 2024
Sleep
disruption
and
impaired
synaptic
processes
are
common
features
in
neurodegenerative
diseases,
including
Alzheimer's
disease
(AD).
Hyperphosphorylated
Tau
is
known
to
accumulate
at
neuronal
synapses
AD,
contributing
synapse
dysfunction.
However,
it
remains
unclear
how
sleep
pathology
interact
contribute
cognitive
decline.
Here,
we
examined
sex-specific
onset
consequences
of
loss
AD/tauopathy
model
PS19
mice.
Using
a
piezoelectric
home-cage
monitoring
system,
showed
mice
exhibited
early-onset
progressive
hyperarousal,
selective
dark-phase
disruption,
apparent
3
months
females
6
males.
the
Morris
water
maze
test,
report
that
chronic
(CSD)
accelerated
decline
hippocampal
spatial
memory
males
only.
Hyperarousal
occurs
well
advance
robust
forebrain
burden
becomes
6–9
months.
To
determine
whether
causal
link
exists
between
hyperphosphorylation,
correlation
behavior
Tau,
or
exposed
acute
While
confirm
driver
hyperphosphorylation
neurons
locus
ceruleus,
were
unable
show
any
synapses.
Despite
finding
hyperarousal
appears
earlier
females,
female
cognition
was
resilient
effects
disruption.
We
conclude
interacts
with
accelerate
greater
vulnerability
Alzheimer s & Dementia,
Journal Year:
2024,
Volume and Issue:
20(6), P. 4260 - 4289
Published: April 30, 2024
Experimental
laboratory
research
has
an
important
role
to
play
in
dementia
prevention.
Mechanisms
underlying
modifiable
risk
factors
for
are
promising
targets
prevention
but
difficult
investigate
human
populations
due
technological
constraints
and
confounds.
Therefore,
controlled
experiments
models
such
as
transgenic
rodents,
invertebrates
vitro
cultured
cells
increasingly
used
test
strategies
which
target
them
prevent
dementia.
This
review
provides
overview
of
experimental
into
15
established
putative
factors:
less
early-life
education,
hearing
loss,
depression,
social
isolation,
life
stress,
hypertension,
obesity,
diabetes,
physical
inactivity,
heavy
alcohol
use,
smoking,
air
pollution,
anesthetic
exposure,
traumatic
brain
injury,
disordered
sleep.
It
explores
how
have
been,
can
be,
address
questions
about
that
cannot
readily
be
addressed
studies.
HIGHLIGHTS:
Modifiable
Interrogation
mechanisms
is
populations.
Studies
using
diverse
revealing
mechanisms.
We
factors.
Laboratory
science
contribute
uniquely
F&S Science,
Journal Year:
2024,
Volume and Issue:
5(3), P. 225 - 231
Published: June 15, 2024
Objective
To
study
whether
male
infertility
and
insomnia
share
genetic
risk
variants,
to
identify
any
molecular,
cellular
biological
interactions
between
these
traits.
Design
The
in
silico
was
performed.
Two
lists
of
genetics
variants
were
manually
curated
through
a
literature
review,
1
those
associated
with
the
other
insomnia.
Genes
assigned
compose
(454
genes)
(921
genes)-associated
gene
lists.
Subjects
Not
applicable.
Intervention
Main
Outcome
Measures
Enrichment
pathways
protein-protein
interaction
(PPI)
analysis.
Results
Twenty-eight
genes
common
both
lists,
representing
greater
overlap
than
would
be
expected
by
chance.
In
28
contained
intersection
list,
there
significant
enrichment
related
kinesin
binding.
A
PPI
analysis
using
list
as
input
retrieved
25
nodes
indicated
that
2
them
kinesin-related
proteins
(PLEKHM2
KCL1).
Conclusions
shared
genes,
highlighted
this
study,
suggest
further
functional
investigations
into
interplay
fertility
sleep
are
warranted.
This
review
examines
the
complex
relationship
between
sleep,
glymphatic
system
and
Alzheimer’s
disease
(AD)
pathogenesis.
It
explores
recent
work
calling
into
question
mechanism
of
clearance
during
thus
for
further
research
to
understand
mechanisms
and/or
uncover
true
sleep.
Methods
measuring
flow
are
reviewed,
suggesting
that
magnetic
resonance
imaging
(MRI)
may
be
best
approach
resolve
this
controversy.
Furthermore,
therapeutic
potential
dual
orexin
receptor
antagonists
(DORAs)
in
mitigating
sleep
disturbances
associated
with
AD.
DORAs
promote
thereby
enhance
regardless
precise
(glymphatic
or
other),
offering
a
promising
avenue
slowing
AD
progression
improving
long
term
patient
outcomes.
More
is
crucial
elucidate
linkage
DORAs,
improved
facilitating
remediation
pathophysiology.